1200万美元首付款,迈威生物双靶点siRNA创新药NewCo出海 1分钟药闻速览

动脉网
Sep 18, 2025

医线药闻:9月16日,康方生物申报的靶向HER3的抗体偶联药物注射用AK138D1获批临床试验默示许可,拟用于治疗晚期恶性肿瘤;9月15日,复星医药子公司开发的CDK4/6抑制剂“枸橼酸伏维西利胶囊”获批新适应症,用于HR阳性、HER2阴性乳腺癌的初始内分泌治疗;近日,恒瑞医药子公司收到关于注射用SHR-1826、阿得贝利单抗注射液、贝伐珠单抗注射液的《药物临床试验批准通知书》;9月15日,白云山...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10